Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Ovid Therapeutics Inc (OVID)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Ovid Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.200 0.000    0.00%
31/12 - Closed. Currency in USD ( Disclaimer )
After Hours
3.260
+0.060
+1.875%
18:20:23 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 130,384
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 3.198 - 3.240
Ovid Therapeutics 3.200 0.000 0.00%

OVID Income Statement

 
Featured here, the Income Statement (earnings report) for Ovid Therapeutics Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 0.142 0.109 0.075 0.066
Revenue 0.142 0.109 0.075 0.066
Other Revenue, Total - - - -
Cost of Revenue, Total - - - -
Gross Profit 0.142 0.109 0.075 0.066
Total Operating Expenses 19.93 12.14 14.25 14.96
Selling/General/Admin. Expenses, Total 9.29 6.81 8.25 8.34
Research & Development 10.64 5.33 6 6.61
Depreciation / Amortization - - - -
Interest Expense (Income) - Net Operating - - - -
Unusual Expense (Income) - - - -
Other Operating Expenses, Total - - - -
Operating Income -19.79 -12.03 -14.17 -14.89
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 1.5 - - 0.36
Other, Net -5.97 -0.776 -1.76 -1.9
Net Income Before Taxes -15.32 -11.25 -12.41 -13.36
Provision for Income Taxes - - - -
Net Income After Taxes -15.32 -11.25 -12.41 -13.36
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items -15.32 -11.25 -12.41 -13.36
Total Extraordinary Items - - - -
Net Income -15.32 -11.25 -12.41 -13.36
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items -15.32 -11.25 -12.41 -13.36
Dilution Adjustment 0.224 0.047 0.288 0.037
Diluted Net Income -15.55 -11.3 -12.7 -13.39
Diluted Weighted Average Shares 70.69 70.62 70.53 70.49
Diluted EPS Excluding Extraordinary Items -0.22 -0.16 -0.18 -0.19
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS -0.163 -0.1 -0.11 -0.122
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

OVID Comments

Write your thoughts about Ovid Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
sante cezza
sante cezza Mar 11, 2024 2:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Chapter 11...tehical default with these revenues
sante cezza
sante cezza Feb 29, 2024 2:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Could be a new chapter 11...
sante cezza
sante cezza Oct 20, 2023 10:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Going down.. Going down
Isto Toivonen
Isto Toivonen Mar 03, 2021 11:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
7 nice target
King David
TheKingDavid Mar 03, 2021 9:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Next target 7.00$
Dong ThreeThousand
Dong ThreeThousand Mar 03, 2021 7:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
expected to rise till ?
Show previous replies (2)
Irshat Mukhametov
Irshat Mukhametov Mar 03, 2021 7:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
6 is the fair value for now but it could be lift upto 15 on momentum trade
Hugh Mckane
Hugh Mckane Mar 03, 2021 7:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
If it hits 15 on momentum trade after 8:30am est conference call; Im selling.
Irshat Mukhametov
Irshat Mukhametov Mar 03, 2021 7:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hugh Mckane  doubt its gonna happen overnight, probably by friday
Dong ThreeThousand
Dong ThreeThousand Mar 03, 2021 7:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Irshat Mukhametov  15 by friday is still alot though... then its a strong buy?
Irshat Mukhametov
Irshat Mukhametov Mar 03, 2021 7:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dong ThreeThousand  I guess so, 15 is aligned with 1 bill valuation, which with money the co is expected to recieve from Takeda is quite achievable
Lázár Csorba
Lázár Csorba Feb 03, 2021 4:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Letsgo back
King David
TheKingDavid Dec 02, 2020 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
250k$ just removed. thanks to OVID.
Gene Emory
Gene Emory Dec 02, 2020 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sorry for your loss. Watch prvb pre fda approval. Good luck!
Ali Budak
Keldede Dec 02, 2020 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gene Emory  what is prvb? i lost 25k, and so sad.
Isto Toivonen
Isto Toivonen Dec 02, 2020 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i hope next 10 bagger
Ab High
Ab High Dec 02, 2020 5:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
to where
Jani Viitaniemi
Jani Viitaniemi Sep 02, 2020 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy
Leo Steven
Leo Steven Sep 02, 2020 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email